InjectSense Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Series C
  • (Cancelled)

  • Investors
  • 4

InjectSense General Information

Description

Developer of an injectable wireless pressure sensor designed to improve therapy procedures. The company's sensors monitor patient profiles for glaucoma and also focus on minimally invasive assistance to generate clinically actionable information for therapy management and outcome, enabling medical professionals to treat glaucoma diseases in an effective, efficient, convenient, and hassle-free manner.

Contact Information

Website
www.injectsense.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2000 Powell Street
  • Suite 1425
  • Emeryville, CA 94608
  • United States
+1 (510)
Primary Industry
Monitoring Equipment
Other Industries
Biotechnology
Other Healthcare Technology Systems
Vertical(s)
Digital Health, HealthTech, Life Sciences, Internet of Things
Corporate Office
  • 2000 Powell Street
  • Suite 1425
  • Emeryville, CA 94608
  • United States
+1 (510)

InjectSense Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

InjectSense Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series C) Cancelled Product Development
7. Later Stage VC 23-Nov-2023 Completed Product Development
6. Grant 17-Mar-2022 Completed Product Development
5. Grant 01-Feb-2022 Completed Product Development
4. Debt - PPP 30-Apr-2020 Completed Startup
3. Later Stage VC (Series B) 23-Apr-2019 Completed Startup
2. Early Stage VC (Series A) 10-Oct-2017 $9.8M $9.8M Completed Startup
1. Seed Round 01-Jan-2016 Completed Startup
To view InjectSense’s complete valuation and funding history, request access »

InjectSense Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B
Series A2
Series A1 1,434,373 $0.001000 8% $1.28 $1.28 1x $1.28 10.89%
To view InjectSense’s complete cap table history, request access »

InjectSense Patents

  • 22

    Total Documents Applications and Grants

  • Total Patents Families

  • 12

    Granted

  • 7

    Pending

  • Expiring in next 12 mo

InjectSense Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230390110-A1 Smart implantable micro device for therapeutic active flow control and associated systems and methods for use Pending 14-Apr-2022
US-20220280038-A1 Circadian intraocular pressure profile and methods of treatment Pending 08-Mar-2021
US-20220117488-A1 Hermetic heterogeneous integration platform for active and passive electronic components Pending 03-Jul-2019
US-20160058324-A1 Ultra low power charging implant sensors with wireless interface for patient monitoring Inactive 02-Sep-2014
EP-3164060-A1 Ultra low power charging implant sensors with wireless interface for patient monitoring Inactive 01-Jul-2014 A61B5/076
To view InjectSense’s complete patent history, request access »

InjectSense Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

InjectSense Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Doliam Venture Capital Minority
National Eye Institute Government
National Institutes of Health Government
Microtech Ventures Venture Capital Minority
To view InjectSense’s complete investors history, request access »

Ready to get started?

Request a free trial

InjectSense FAQs

  • When was InjectSense founded?

    InjectSense was founded in 2014.

  • Where is InjectSense headquartered?

    InjectSense is headquartered in Emeryville, CA.

  • What is the size of InjectSense?

    InjectSense has 13 total employees.

  • What industry is InjectSense in?

    InjectSense’s primary industry is Monitoring Equipment.

  • Is InjectSense a private or public company?

    InjectSense is a Private company.

  • What is InjectSense’s current revenue?

    The current revenue for InjectSense is .

  • How much funding has InjectSense raised over time?

    InjectSense has raised $16.4M.

  • Who are InjectSense’s investors?

    Doliam, National Eye Institute, National Institutes of Health, and Microtech Ventures have invested in InjectSense.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »